GENE ONLINE|News &
Opinion
Blog

2026-02-08|

TG Therapeutics Partners with Christina Applegate to Raise Awareness About Multiple Sclerosis

by GOAI
Share To

TG Therapeutics has announced a collaboration with actress Christina Applegate to raise awareness about multiple sclerosis (MS). The partnership aims to highlight the challenges faced by individuals living with MS and promote education about the condition. Christina Applegate, who was diagnosed with MS in 2021, will work alongside TG Therapeutics to share her personal experiences and advocate for greater understanding of the disease.

The collaboration comes as part of TG Therapeutics’ ongoing efforts to support patients and provide resources related to MS. The company focuses on developing treatments for B-cell diseases, including relapsing forms of multiple sclerosis. Through this initiative, TG Therapeutics plans to leverage Applegate’s public platform to amplify conversations around MS and its impact on daily life. Further details regarding specific campaigns or events tied to this partnership have not yet been disclosed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
Scroll to Top